TG Therapeutics (TGTX) Misses Q3 EPS by 19c

November 7, 2016 7:34 AM EST
Get Alerts TGTX Hot Sheet
Trade TGTX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.50), $0.19 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $38.1 thousand versus the consensus estimate of $30 thousand.

Cash, cash equivalents, investment securities, and interest receivable were $60.7 million as of September 30, 2016.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment